Pulse Biosciences (PLSE) Cash from Investing Activities Growth (1y) (2016 - 2025)
Pulse Biosciences (PLSE) Cash from Investing Activities Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | -110.20% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | -4.51% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -4.35% |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -82.56% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | 42.55% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | 32.46% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | -13.64% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | -420.31% |
| 10 | Pulse Biosciences | 2.23 Bn | 2.15 Bn | - | -98.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -98.11% |
| Sep 30, 2025 | -63.16% |
| Jun 30, 2025 | -324.14% |
| Mar 31, 2025 | -800.00% |
| Dec 31, 2024 | -23.26% |
| Sep 30, 2024 | -65.22% |
| Jun 30, 2024 | -81.25% |
| Mar 31, 2024 | 87.18% |
| Dec 31, 2023 | -4.88% |
| Sep 30, 2023 | 62.90% |
| Jun 30, 2023 | 15.79% |
| Mar 31, 2023 | 86.02% |
| Dec 31, 2022 | 69.40% |
| Sep 30, 2022 | 60.51% |
| Jun 30, 2022 | 80.00% |
| Mar 31, 2022 | -103.51% |
| Dec 31, 2021 | -100.94% |
| Sep 30, 2021 | 99.30% |
| Jun 30, 2021 | -101.18% |
| Mar 31, 2021 | -23.00% |